Mark Frohlich
Signal active
Chief Executive Officer
Bio
Mark Frohlich is the CEO at Indapta Therapeutics. Mark Frohlich attended University of California, San Francisco.
Location
Greater Seattle Area, Washington, United States, North America
Social
Primary Organization
Indapta Therapeutics
Founded
2017
Employees
1-10
Industry
Biotechnology, Medical, Biopharma
Board and Advisor Roles
1
N/A
Invest in regions
Profile Resume
Mark Frohlich is the Chief Executive Officer at Indapta Therapeutics, based in United States, North America. With a background in Biotechnology, Mark Frohlich has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity